Immucell Corp (ICCC) Reports Q4 EPS of $0.06
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of $0.06. Revenue for the quarter came in at $7.8 million.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Viatris (VTRS) at Outperform
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- AstraZeneca extends Young Health Programme with $100m total investment
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
